Immune Status of Blood Product Recipients

Janine Jason, Margaret Hilgartner, Robert C. Holman, Gloria Dixon, Thomas J. Spira, Louis Aledort, Bruce Evatt

Research output: Contribution to journalArticlepeer-review

39 Scopus citations


Persons with hemophilia are at risk of the acquired immunodeficiency syndrome (AIDS), and clinically asymptomatic hemophiliacs have shown a high incidence of AIDS-like immune abnormalities, facts leading to speculation that many hemophiliacs have been exposed to the AIDS agent through their blood products. We therefore evaluated the immune status of three groups of blood product recipients without AIDS in New York City, including 47 persons with hemophilia A receiving factor VIII concentrate, 50 persons with homozygous β-thalassemia, and 27 persons with sickle cell anemia receiving frozen-packed RBCs and 20 healthy persons who had not received a transfusion. Hemophiliac participants had significantly lower lymphocyte counts (median, 1,826/cu mm) than did the thalassemic (6,110/cu mm) or anemic (4,443/cu mm) participants, had lower numbers of T-helper lymphocytes (median, 533 cells/cu mm v 1,733 cells/cu mm and 1,554 cells/cu mm), and had a lower T-helper/suppressor ratio (median, 0.8 v 1.8 and 2.1). These differences remained after adjustment for age and sex. Thus, AIDS-like immune abnormalities were found in patients receiving factor concentrate, but not in those receiving RBCs. These defects could be due to both an immunosuppressive effect of the lyophilized factor itself and to contact with the AIDS agent.

Original languageEnglish
Pages (from-to)1140-1145
Number of pages6
JournalJAMA - Journal of the American Medical Association
Issue number8
StatePublished - 22 Feb 1985


Dive into the research topics of 'Immune Status of Blood Product Recipients'. Together they form a unique fingerprint.

Cite this